SILVERARC CAPITAL MANAGEMENT, LLC Horizon Therapeutics Public Limited Company Transaction History

SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:

$627,000
portfolio value

SILVERARC CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-22.40%
quarter

Horizon Therapeutics Public Limited Company 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -85.97% -62.05K shares -5.13M $61.89 10.13K
Q2 2022 share Increase +7.04% 4.74K shares -1.33M $79.76 72.18K
Q1 2022 share Increase +9.31% 5.74K shares 447K $105.21 67.44K
Q4 2021 share Increase +17.59% 9.23K shares 902K $108.26 61.7K
Q3 2021 share Increase +4.86% 2.43K shares 1.06M $109.54 52.46K
Q2 2021 share Increase +3.22% 1.55K shares 223K $93.64 50.03K
Q1 2021 share Increase +61.59% 18.47K shares 2.26M $92.04 48.47K
Q4 2020 share Increase 0.00% 30K shares 2.19M $73.15 30K